Integrated device for blood based lateral flow rapid testing

Atomo Diagnostics has developed MicroRapid, a fully integrated rapid test device for blood based lateral flow immunoassay diagnostics. It is a platform technology for sampling, collecting and testing capillary blood using immunoassay diagnostics. This market includes the diagnosis of a wide range of infectious diseases, cardiac  and cancer markers. MicroRapid replaces the need for test kits containing many separate devices and reduces handling and errors. The company intends to prepare 1,500 sterile fully functional production prototypes of the MicroRapid test device.

Commercialisation Australia funding will enable a number of international customers to carry out commercial evaluation of the test device. In addition, Atomo Diagnostics will perform usability evaluations and performance assessments to support commercialisation and ultimately the launch of the product.